The adverse events most commonly reported were dry mouth, nasopharyngitis, and constipation.

The most commonly reported adverse events were nasopharyngitis, headache, and upper respiratory tract infection.

Conjunctival hemorrhage was the most common ocular, whereas nasopharyngitis and hypertension were the most common nonocular adverse events.

In the late-stage trial, the most common side-effects to the drug included headache, muscle pain, flushing, nasopharyngitis and respiratory tract infection.

Most of adverse events (AE) were mild in nature, the commonest adverse events were elevated liver function levels, injection site reactions and nasopharyngitis.